Repare Therapeutics Inc.
(RPTX)
undefined
undefined%
At close: undefined
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Cash & Equivalents | 111.27M | 159.52M | 334.43M | 326.18M | 94.80M | 10.73M |
Short-Term Investments | 112.36M | 184.42M | 7.44M | 7.53M | - | - |
Long-Term Investments | - | - | - | 212.00K | 208.00K | 198.00K |
Other Long-Term Assets | 2.67M | 497.00K | 586.00K | 500.00K | 567.00K | 27.00K |
Receivables | 15.31M | 4.32M | 3.23M | 6.16M | 3.06M | 1.06M |
Inventory | - | -2.81M | - | - | - | - |
Other Current Assets | 4.75M | 5.71M | 6.31M | 6.68M | 719.00K | 253.00K |
Total Current Assets | 243.69M | 353.98M | 351.41M | 346.55M | 98.57M | 12.05M |
Property-Plant & Equipment | 7.54M | 9.60M | 13.10M | 8.62M | 3.42M | 1.65M |
Goodwill & Intangibles | - | - | - | -212.00K | -208.00K | - |
Total Long-Term Assets | 10.21M | 10.10M | 17.30M | 10.53M | 4.12M | 1.88M |
Total Assets | 253.90M | 364.07M | 368.71M | 357.09M | 102.69M | 13.93M |
Account Payables | 2.40M | 461.00K | 2.30M | 2.25M | 2.13M | 1.25M |
Deferred Revenue | 10.22M | 53.10M | 11.92M | 2.07M | 1.49M | - |
Short-Term Debt | 4.80M | 4.34M | 3.44M | 1.39M | 625.00K | - |
Other Current Liabilities | 21.66M | 19.47M | 16.90M | 5.28M | 1.28M | 660.00K |
Total Current Liabilities | 39.08M | 78.62M | 35.09M | 11.01M | 4.25M | 1.91M |
Long-Term Debt | 2.02M | 6.51M | 11.18M | 6.62M | 439.00K | 2.49M |
Other Long-Term Liabilities | -1.01M | -3.26M | -5.59M | -3.31M | 136.00M | 31.91M |
Total Long-Term Liabilities | 2.74M | 5.94M | 45.20M | 59.24M | 144.58M | 34.40M |
Total Liabilities | 41.82M | 84.56M | 80.29M | 70.26M | 148.82M | 36.31M |
Total Debt | 3.41M | 5.43M | 7.31M | 4.00M | 1.06M | 2.49M |
Common Stock | 483.35M | 482.03M | 480.70M | 384.31M | 1K | 1K |
Retained Earnings | -333.11M | -239.31M | -210.27M | -103.36M | -49.94M | -22.73M |
Comprehensive Income | 28.00K | -428.00K | -0.00 | - | -136.00M | -490.00K |
Shareholders Equity | 212.08M | 279.52M | 288.42M | 286.83M | -46.13M | -22.38M |
Total Investments | 112.36M | 184.42M | 7.44M | 7.53M | 208.00K | 198.00K |